INFECTIONS IN LIVER-TRANSPLANT PATIENTS - ANALYSIS OF 51 PATIENTS

被引:1
|
作者
DUPON, M
LEMOIGNE, E
RYMAN, A
PATY, MC
WINNOCK, S
JANVIER, G
SARIC, J
LACUT, JY
机构
来源
MEDECINE ET MALADIES INFECTIEUSES | 1991年 / 21卷 / 07期
关键词
LIVER TRANSPLANTATION; INFECTIONS; IMMUNOSUPPRESSION; ANTIBIOPROPHYLAXIS;
D O I
10.1016/S0399-077X(05)80143-X
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We studied severe infections which occured in 51 liver transplant recipients between july 1986 and december 1989 (age range 4-67 years). The overall mortality was 18/51 (35,3%) and 6 deaths were due to infection; 4 patients underwent a second transplant procedure because of recurrence of hepatitis B. All patients received an antimicrobial prophylaxis (piperacillin +/- teicoplanin IV for 48 h +/- oral nystatin +/- oral norfloxacin for 15 days). 38/51 patients had a severe infectious episode, 14 due to one type of micro-organism, 20 due to two types, 4 due to three types (bacterial +/- viral +/- fungal). 66% of the episodes of infection occured in the first month and 97% in the first three months after transplantation. Of the 112 infections, 69 (61,6%) were bacterial: 28,6% due to Gram positive bacteria (23,2% due to Staphylococcus), 29,4% due to Gram negative bacteria (9,8% due to Pseudomonas) and 3,6% due to anaerobic organisms. 37/112 (33%) were viral infections (14,3% due to Cytomegalovirus) and 6/112 (5,4%) were fungal. Among the 139 locations, 42 (30,2%) were bacteriemia, viremia or fungemia, 18 (12,9%) were soft tissue manifestations, 15 (10,8%) were hepatitis, 13 (9,3%) were pneumonia, 12 (8,6%) were cholangitis, 11 (7,9%) were oropharyngeal. 10 (7,2%) were peritonitis and 6 (4,3%) involved digestive mucosa.
引用
下载
收藏
页码:399 / 405
页数:7
相关论文
共 50 条
  • [31] STEROID-METABOLISM IN LIVER-TRANSPLANT PATIENTS
    VENKATARAMANAN, R
    HUANG, ML
    DELAMOS, B
    BURCKART, GJ
    PTACHCINSKI, RJ
    VANTHIEL, DH
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 2452 - 2452
  • [32] NUTRITION IN PATIENTS UNDERGOING ORTHOTOPIC LIVER-TRANSPLANT
    HEHIR, DJ
    JENKINS, RL
    BISTRIAN, BR
    BLACKBURN, GL
    JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 1985, 9 (06) : 695 - 700
  • [33] MAIN AUTOPSY FINDINGS IN LIVER-TRANSPLANT PATIENTS
    MARKIN, RS
    HOLLINS, S
    WOOD, RP
    SHAW, BW
    MODERN PATHOLOGY, 1989, 2 (04) : 339 - 348
  • [34] LIVER-TRANSPLANT IN PATIENTS WITH CIRRHOSIS OF THE LIVER - THE PROBLEM OF THE RIGHT MOMENT
    LAUTZ, HU
    BECHSTEIN, WO
    RINGE, B
    LAUCHART, W
    SCHMIDT, FW
    PICHLMAYR, R
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1987, 25 (01): : 81 - 82
  • [35] ADENOVIRAL INFECTIONS IN PEDIATRIC LIVER-TRANSPLANT RECIPIENTS
    KONERU, B
    JAFFE, R
    ESQUIVEL, CO
    KUNZ, R
    TODO, S
    IWATSUKI, S
    STARZL, TE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (04): : 489 - 492
  • [36] FUNGAL-INFECTIONS IN LIVER-TRANSPLANT RECIPIENTS
    GRAUHAN, O
    LOHMANN, R
    LEMMENS, P
    SCHATTENFROH, N
    KECK, H
    KLEIN, E
    RAAKOW, R
    JONAS, S
    LANGREHR, JM
    BECHSTEIN, W
    BLUMHARDT, G
    NEUHAUS, P
    LANGENBECKS ARCHIV FUR CHIRURGIE, 1994, 379 (06): : 372 - 375
  • [37] FUNGAL-INFECTIONS IN LIVER-TRANSPLANT RECIPIENTS
    WAJSZCZUK, CP
    DUMMER, JS
    HO, M
    VANTHIEL, DH
    STARZL, TE
    IWATSUKI, S
    SHAW, B
    TRANSPLANTATION, 1985, 40 (04) : 347 - 353
  • [38] CYCLOSPORINE TROUGH CONCENTRATION MONITORING IN LIVER-TRANSPLANT PATIENTS
    BURCKART, GJ
    PTACHCINSKI, RJ
    VENKATARAMANAN, R
    IWATSUKI, S
    ESQUIVEL, C
    VANTHIEL, DH
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1986, 18 (06) : 188 - 193
  • [39] US liver-transplant policy favours acute patients
    Firshein, J
    LANCET, 1996, 348 (9040): : 1508 - 1508
  • [40] CEFTIZOXIME AND CEFOTAXIME PHARMACOKINETICS IN PEDIATRIC LIVER-TRANSPLANT PATIENTS
    BURCKART, GJ
    JONES, D
    PTACHCINSKI, R
    SHAW, B
    STARZL, TE
    VENKATARAMANAN, R
    HOWRIE, D
    IWATSUKI, S
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1985, 19 (06): : 450 - 451